RCEL
insider transactionsAVITA Medical, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
+45.2K
45.2K buy · 0 sell
Net value · 30d
$188.6K
$188.6K in · $0 out
Sentiment · 30d
Net buying
100% buying · 0% selling
Open-market trades · 30d
9
45.2K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
David D O'Toole KEY
CFO
$7.9K
2.0K sh · $3.97
Own +1%
-
Buy·P
Director
$20.9K
5.0K sh · $4.18
Own +5%
-
Buy·P
Director
$21.0K
5.0K sh · $4.20
Own +5%
-
Buy·P
Director
$20.8K
5.2K sh · $4.00
Own +5%
-
Buy·P
Director
$20.4K
5.0K sh · $4.09
Own +6%
-
Buy·P
Director
$20.5K
5.0K sh · $4.10
Own +6%
-
Buy·P
Director
$21.0K
5.0K sh · $4.21
Own +33%
-
Buy·P
Director
$20.9K
5.0K sh · $4.18
Own +50%
-
Buy·P
Director
$21.3K
5.0K sh · $4.26
Own +100%
-
Buy·P
Director
$21.7K
5.0K sh · $4.34
Own New
-
Grant·A
David D O'Toole KEY
CFO
$15.3K
5.0K sh · $3.05
Own +3%
-
Grant·A
Cary Guy Vance KEY
President and CEO
$15.3K
5.0K sh · $3.05
Own +14%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | David D O'Toole KEY | Grant A | 2.0K | $7.9K |
| Jun 9, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $20.9K |
| Jun 9, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $21.0K |
| Jun 9, 2026 | Joseph Fralin Woody | Buy P | 5.2K | $20.8K |
| Jun 3, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $20.4K |
| Jun 3, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $20.5K |
| Jun 2, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $21.0K |
| Jun 2, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $20.9K |
| Jun 1, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $21.3K |
| Jun 1, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $21.7K |
| May 29, 2026 | David D O'Toole KEY | Grant A | 5.0K | $15.3K |
| May 29, 2026 | Cary Guy Vance KEY | Grant A | 5.0K | $15.3K |
About RCEL insider trading
This page tracks insider transactions for AVITA Medical, Inc. (RCEL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.